Company research
PureTech Health plc
CIK 1782999Updated Sep 24, 2026
SecuritiesPTCHF · OTC · equityPRTCY · OTC · adr
PTCHF price & chart
Loading TradingView…
OTC:PTCHF on TradingView ↗In the news
No coverage from other publishers is available.
Seeking Alpha
PureTech Health plc (PRTCY) Q2 2026 Earnings Call Transcript ↗
PureTech Health plc 2025 Q4 - Results - Earnings Call Presentation ↗
SEC disclosures
PureTech Health plc files prospectus supplement (424B3) ↗
Financials
FY 2024 · USDSource
Source
Source
Source
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossUSD | 27,782,000Source | -66,628,000Source | -37,065,000Source | -62,709,000Source |
| Additional Financial Items | ||||
| AdjustmentsForFinanceCostsUSD | — | — | — | -5,050,000Source |
| AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesUSD | 151,808,000Source | 61,787,000Source | 27,251,000Source | 0Source |
| AdjustmentsForIncomeTaxExpenseUSD | -4,008,000Source | 30,525,000Source | -55,719,000Source | 3,756,000Source |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableUSD | -9,695,000Source | 3,844,000Source | 22,033,000Source | 8,338,000Source |
| AdjustmentsForSharebasedPaymentsUSD | 22,850,000Source | 4,415,000Source | 14,698,000Source | 13,950,000Source |
| GeneralAndAdministrativeExpenseUSD | 71,469,000Source | 53,295,000Source | 60,991,000Source | 57,199,000Source |
| IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesUSD | 37,913,000Source | 150,000Source | 20,696,000Source | 27,766,000Source |
| InterestPaidClassifiedAsOperatingActivitiesUSD | 1,295,000Source | 1,701,000Source | 3,366,000Source | 3,382,000Source |
| InterestReceivedClassifiedAsOperatingActivitiesUSD | 23,547,000Source | 14,454,000Source | 3,460,000Source | 214,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | 3,394,000Source | 3,338,000Source | 4,025,000Source | 3,375,000Source |
| ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivitiesUSD | 255,000Source | 865,000Source | 0Source | 30,000Source |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD | 0Source | 175,000Source | 0Source | 90,000Source |
| PurchaseOfInterestsInAssociatesUSD | 14,400,000Source | 0Source | 19,961,000Source | — |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Total RevenueUSD | 4,828,000Source | 3,330,000Source | 15,618,000Source | 17,388,000Source |
| Additional Financial Items | ||||
| ApplicableTaxRatenumber | 0.21Source | 0.21Source | 0.21Source | 0.21Source |
| AverageEffectiveTaxRatenumber | -0.17Source | -0.85Source | 0.6Source | -0.06Source |
| BasicEarningsLossPerShareUSD per share | 0.21Source | -0.24Source | -0.18Source | -0.21Source |
| CurrentTaxExpenseIncomeUSD | 48,454,000Source | -2,292,000Source | 14,401,000Source | 22,247,000Source |
| DeferredTaxExpenseIncomeUSD | -52,462,000Source | 32,817,000Source | -70,120,000Source | -18,491,000Source |
| DeferredTaxExpenseIncomeRecognisedInProfitOrLossUSD | -4,008,000Source | 30,525,000Source | -55,719,000Source | 3,756,000Source |
| DepreciationAndAmortisationExpenseUSD | 3,571,000Source | 4,933,000Source | — | — |
| DepreciationRightofuseAssetsUSD | 1,764,000Source | 1,979,000Source | 3,047,000Source | 2,938,000Source |
| DilutedEarningsLossPerShareUSD per share | 0.21Source | -0.24Source | -0.18Source | -0.21Source |
| EmployeeBenefitsExpenseUSD | 2,203,000Source | 2,599,000Source | 2,908,000Source | 2,563,000Source |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesUSD | 22,850,000Source | 4,415,000Source | 14,699,000Source | 13,950,000Source |
| FinanceCostsUSD | 1,731,000Source | 3,424,000Source | 3,939,000Source | 4,771,000Source |
| FinanceIncomeUSD | 22,669,000Source | 16,012,000Source | 5,799,000Source | 214,000Source |
| GainsLossesRecognisedWhenControlInSubsidiaryIsLostUSD | 151,808,000Source | 61,787,000Source | 27,251,000Source | 0Source |
| GeneralAndAdministrativeExpenseUSD | 71,469,000Source | 53,295,000Source | 60,991,000Source | 57,199,000Source |
| ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillUSD | — | — | 162,500Source | — |
| IncomeTaxExpenseContinuingOperationsUSD | -4,008,000Source | 30,525,000Source | -55,719,000Source | 3,756,000Source |
| InterestExpenseOnLeaseLiabilitiesUSD | 1,295,000Source | 1,544,000Source | 1,982,000Source | 2,181,000Source |
| OtherIncomeUSD | — | — | — | 159,983,000Source |
| OtherOperatingIncomeExpenseUSD | 163,652,000Source | 111,072,000Source | -25,981,000Source | — |
| ProfitLossAttributableToNoncontrollingInterestsUSD | -25,728,000Source | -931,000Source | 13,290,000Source | -2,151,000Source |
| ProfitLossAttributableToOwnersOfParentUSD | 53,510,000Source | -65,697,000Source | -50,354,000Source | -60,558,000Source |
| ProfitLossBeforeTaxUSD | 23,774,000Source | -36,103,000Source | -92,783,000Source | -58,953,000Source |
| ProfitLossFromOperatingActivitiesUSD | -136,095,000Source | -146,199,000Source | -197,807,000Source | -150,282,000Source |
| ResearchAndDevelopmentExpenseUSD | 69,454,000Source | 96,235,000Source | 152,433,000Source | 110,471,000Source |
| ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodUSD | -8,754,000Source | -6,055,000Source | -27,749,000Source | -73,703,000Source |